首页> 美国卫生研究院文献>other >The compensatory renin-angiotensin system in the central regulation of arterial pressure: New avenues and new challenges
【2h】

The compensatory renin-angiotensin system in the central regulation of arterial pressure: New avenues and new challenges

机译:补偿性肾素-血管紧张素系统在动脉压力的中央调节:新途径和新挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypertension is a widespread condition that affects millions of people around the world and has a great impact in public health. The classic Renin Angiotensin System is a complex system comprised of multiple peptides and pathways that have been the motive of great drug development over the years to control hypertension. However, there are still patients whose hypertension is very difficult to control with the current drugs and strategies, thus motivating further research in this field. In the last two decades, important discoveries have expanded our knowledge of this system and new pathways are emerging that are helping us understand the complex interaction taking place not only in the periphery but also in the central nervous system where the renin angiotensin system is also very active. A new arm, called the ACE2/Ang-(1-7)/Mas receptor axis was shown to exert anti-hypertensive properties and serve as a counterbalance to the classic ACE/Angiotensin-II/AT1 receptor axis; in this way, modulating or even counteracting the negative effects of Angiotensin-II in blood pressure regulation and water retention. Modulation of this new axis through ACE2 activation, ADAM17 regulation or AT1 receptor internalization are some of the novel avenues and challenges that have the potential to become target for new drug research and development for the treatment of hypertension.
机译:高血压是一种普遍的疾病,影响着世界各地的数百万人,并对公共卫生产生了巨大影响。经典的肾素血管紧张素系统是一个复杂的系统,由多种肽和多种途径组成,多年来一直是控制高血压的重要药物开发动机。但是,仍然有一些高血压患者很难用当前的药物和策略来控制,因此激发了该领域的进一步研究。在过去的二十年中,重要的发现扩展了我们对该系统的了解,并且出现了新的途径,这些途径不仅帮助我们了解周围的复杂相互作用,而且还了解了肾素血管紧张素系统也非常复杂的中枢神经系统活性。研究表明,一种名为ACE2 / Ang-(1-7)/ Mas受体轴的新臂具有抗高血压特性,可与经典的ACE / Angiotensin-II / AT1受体轴形成平衡。通过这种方式,可以调节甚至抵消血管紧张素II在血压调节和保水方面的负面影响。通过ACE2激活,ADAM17调节或AT1受体内在化来调节这一新轴是一些新颖的途径和挑战,这些新途径和挑战有可能成为治疗高血压的新药研究和开发的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号